Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 179

1.

Vitamin C therapy for patients with sepsis or septic shock: a protocol for a systematic review and a network meta-analysis.

Fujii T, Belletti A, Carr A, Furukawa TA, Luethi N, Putzu A, Sartini C, Salanti G, Tsujimoto Y, Udy AA, Young PJ, Bellomo R.

BMJ Open. 2019 Nov 12;9(11):e033458. doi: 10.1136/bmjopen-2019-033458.

2.

Extensions of the probabilistic ranking metrics of competing treatments in network meta-analysis to reflect clinically important relative differences on many outcomes.

Mavridis D, Porcher R, Nikolakopoulou A, Salanti G, Ravaud P.

Biom J. 2019 Oct 29. doi: 10.1002/bimj.201900026. [Epub ahead of print]

3.

Personalise antidepressant treatment for unipolar depression combining individual choices, risks and big data (PETRUSHKA): rationale and protocol.

Tomlinson A, Furukawa TA, Efthimiou O, Salanti G, De Crescenzo F, Singh I, Cipriani A.

Evid Based Ment Health. 2019 Oct 23. pii: ebmental-2019-300118. doi: 10.1136/ebmental-2019-300118. [Epub ahead of print]

4.

Comparative fertility and pregnancy outcomes after local treatment for cervical intraepithelial neoplasia and stage 1a1 cervical cancer: protocol for a systematic review and network meta-analysis from the CIRCLE group.

Athanasiou A, Veroniki AA, Efthimiou O, Kalliala I, Naci H, Bowden S, Paraskevaidi M, Martin-Hirsch P, Bennett P, Paraskevaidis E, Salanti G, Kyrgiou M.

BMJ Open. 2019 Oct 21;9(10):e028009. doi: 10.1136/bmjopen-2018-028009.

5.

Acute interventions for aggression and agitation in psychosis: study protocol for a systematic review and network meta-analysis.

Ostinelli EG, D'Agostino A, Shokraneh F, Salanti G, Furukawa TA.

BMJ Open. 2019 Oct 10;9(10):e032726. doi: 10.1136/bmjopen-2019-032726.

6.

A comparison of arm-based and contrast-based models for network meta-analysis.

White IR, Turner RM, Karahalios A, Salanti G.

Stat Med. 2019 Nov 30;38(27):5197-5213. doi: 10.1002/sim.8360. Epub 2019 Oct 3.

7.

Optimal dosing of antidepressant drugs - Authors' reply.

Furukawa TA, Cowen PJ, Salanti G, Leucht S, Egger M, Cipriani A.

Lancet Psychiatry. 2019 Oct;6(10):806-807. doi: 10.1016/S2215-0366(19)30339-6. No abstract available.

PMID:
31544758
8.

Comparative efficacy and complication rates after local treatment for cervical intraepithelial neoplasia and stage 1a1 cervical cancer: protocol for a systematic review and network meta-analysis from the CIRCLE Group.

Athanasiou A, Veroniki AA, Efthimiou O, Kalliala I, Naci H, Bowden S, Paraskevaidi M, Martin-Hirsch P, Bennett P, Paraskevaidis E, Salanti G, Kyrgiou M.

BMJ Open. 2019 Aug 2;9(8):e028008. doi: 10.1136/bmjopen-2018-028008.

9.

Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis.

Siontis GCM, Overtchouk P, Cahill TJ, Modine T, Prendergast B, Praz F, Pilgrim T, Petrinic T, Nikolakopoulou A, Salanti G, Søndergaard L, Verma S, Jüni P, Windecker S.

Eur Heart J. 2019 Oct 7;40(38):3143-3153. doi: 10.1093/eurheartj/ehz275.

PMID:
31329852
10.

Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis.

Huhn M, Nikolakopoulou A, Schneider-Thoma J, Krause M, Samara M, Peter N, Arndt T, Bäckers L, Rothe P, Cipriani A, Davis J, Salanti G, Leucht S.

Lancet. 2019 Sep 14;394(10202):939-951. doi: 10.1016/S0140-6736(19)31135-3. Epub 2019 Jul 11. Erratum in: Lancet. 2019 Sep 14;394(10202):918.

11.

Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis.

Furukawa TA, Cipriani A, Cowen PJ, Leucht S, Egger M, Salanti G.

Lancet Psychiatry. 2019 Jul;6(7):601-609. doi: 10.1016/S2215-0366(19)30217-2. Epub 2019 Jun 6.

12.

Synthesizing existing evidence to design future trials: survey of methodologists from European institutions.

Nikolakopoulou A, Trelle S, Sutton AJ, Egger M, Salanti G.

Trials. 2019 Jun 7;20(1):334. doi: 10.1186/s13063-019-3449-6.

13.

Network meta-analysis of rare events using the Mantel-Haenszel method.

Efthimiou O, Rücker G, Schwarzer G, Higgins JPT, Egger M, Salanti G.

Stat Med. 2019 Jul 20;38(16):2992-3012. doi: 10.1002/sim.8158. Epub 2019 Apr 17.

PMID:
30997687
14.

Side effect profile and comparative tolerability of 21 antidepressants in the acute treatment of major depression in adults: protocol for a network meta-analysis.

Tomlinson A, Efthimiou O, Boaden K, New E, Mather S, Salanti G, Imai H, Ogawa Y, Tajika A, Kishimoto S, Kikuchi S, Chevance A, Furukawa TA, Cipriani A.

Evid Based Ment Health. 2019 May;22(2):61-66. doi: 10.1136/ebmental-2019-300087. Epub 2019 Apr 17.

PMID:
30996028
15.

Allowing for informative missingness in aggregate data meta-analysis with continuous or binary outcomes: Extensions to metamiss.

Chaimani A, Mavridis D, Higgins JPT, Salanti G, White IR.

Stata J. 2018 Jul 1;18(3):716-740.

16.

Evidence synthesis, practice guidelines and real-world prescriptions of new generation antidepressants in the treatment of depression: a protocol for cumulative network meta-analyses and meta-epidemiological study.

Luo Y, Chaimani A, Kataoka Y, Ostinelli EG, Ogawa Y, Cipriani A, Salanti G, Furukawa TA.

BMJ Open. 2018 Dec 9;8(12):e023222. doi: 10.1136/bmjopen-2018-023222.

17.

The use of mathematical modeling studies for evidence synthesis and guideline development: A glossary.

Porgo TV, Norris SL, Salanti G, Johnson LF, Simpson JA, Low N, Egger M, Althaus CL.

Res Synth Methods. 2019 Mar;10(1):125-133. doi: 10.1002/jrsm.1333. Epub 2019 Jan 8.

18.

Systematic review with network meta-analysis: the impact of medical interventions for moderate-to-severe ulcerative colitis on health-related quality of life.

Paschos P, Katsoula A, Salanti G, Giouleme O, Athanasiadou E, Tsapas A.

Aliment Pharmacol Ther. 2018 Dec;48(11-12):1174-1185. doi: 10.1111/apt.15005. Epub 2018 Oct 30.

PMID:
30378141
19.

Allowing for uncertainty due to missing and LOCF imputed outcomes in meta-analysis.

Mavridis D, Salanti G, Furukawa TA, Cipriani A, Chaimani A, White IR.

Stat Med. 2019 Feb 28;38(5):720-737. doi: 10.1002/sim.8009. Epub 2018 Oct 22.

20.

Network meta-analysis of antidepressants - Authors' reply.

Cipriani A, Salanti G, Furukawa TA, Turner E, Ioannidis JPA, Geddes JR.

Lancet. 2018 Sep 22;392(10152):1012-1013. doi: 10.1016/S0140-6736(18)31780-X. Epub 2018 Sep 20. No abstract available.

PMID:
30264703
21.

Psychological interventions to reduce positive symptoms in schizophrenia: systematic review and network meta-analysis.

Bighelli I, Salanti G, Huhn M, Schneider-Thoma J, Krause M, Reitmeir C, Wallis S, Schwermann F, Pitschel-Walz G, Barbui C, Furukawa TA, Leucht S.

World Psychiatry. 2018 Oct;17(3):316-329. doi: 10.1002/wps.20577.

22.

Methods to calculate uncertainty in the estimated overall effect size from a random-effects meta-analysis.

Veroniki AA, Jackson D, Bender R, Kuss O, Langan D, Higgins JPT, Knapp G, Salanti G.

Res Synth Methods. 2019 Mar;10(1):23-43. doi: 10.1002/jrsm.1319. Epub 2018 Oct 9.

23.

Prediction of Real-World Drug Effectiveness Prelaunch: Case Study in Rheumatoid Arthritis.

Didden EM, Ruffieux Y, Hummel N, Efthimiou O, Reichenbach S, Gsteiger S, Finckh A, Fletcher C, Salanti G, Egger M; IMI GetReal Work Package 4.

Med Decis Making. 2018 Aug;38(6):719-729. doi: 10.1177/0272989X18775975.

PMID:
30074882
24.

Second-generation antipsychotic drugs and short-term mortality: a systematic review and meta-analysis of placebo-controlled randomised controlled trials.

Schneider-Thoma J, Efthimiou O, Huhn M, Krause M, Reichelt L, Röder H, Davis JM, Salanti G, Leucht S.

Lancet Psychiatry. 2018 Aug;5(8):653-663. doi: 10.1016/S2215-0366(18)30177-9. Epub 2018 Jul 2.

PMID:
30042077
25.

Planning a future randomized clinical trial based on a network of relevant past trials.

Salanti G, Nikolakopoulou A, Sutton AJ, Reichenbach S, Trelle S, Naci H, Egger M.

Trials. 2018 Jul 11;19(1):365. doi: 10.1186/s13063-018-2740-2.

26.

How Many Patients With Schizophrenia Do Not Respond to Antipsychotic Drugs in the Short Term? An Analysis Based on Individual Patient Data From Randomized Controlled Trials.

Samara MT, Nikolakopoulou A, Salanti G, Leucht S.

Schizophr Bull. 2019 Apr 25;45(3):639-646. doi: 10.1093/schbul/sby095.

PMID:
29982701
27.

Impact of placebo arms on outcomes in antidepressant trials: systematic review and meta-regression analysis.

Salanti G, Chaimani A, Furukawa TA, Higgins JPT, Ogawa Y, Cipriani A, Egger M.

Int J Epidemiol. 2018 Oct 1;47(5):1454-1464. doi: 10.1093/ije/dyy076.

28.

Cognitive-Behavioral Analysis System of Psychotherapy, Drug, or Their Combination for Persistent Depressive Disorder: Personalizing the Treatment Choice Using Individual Participant Data Network Metaregression.

Furukawa TA, Efthimiou O, Weitz ES, Cipriani A, Keller MB, Kocsis JH, Klein DN, Michalak J, Salanti G, Cuijpers P, Schramm E.

Psychother Psychosom. 2018;87(3):140-153. doi: 10.1159/000489227. Epub 2018 May 30. Review.

PMID:
29847831
29.

60 years of placebo-controlled antipsychotic drug trials in acute schizophrenia: Meta-regression of predictors of placebo response.

Leucht S, Chaimani A, Leucht C, Huhn M, Mavridis D, Helfer B, Samara M, Cipriani A, Geddes JR, Salanti G, Davis JM.

Schizophr Res. 2018 Nov;201:315-323. doi: 10.1016/j.schres.2018.05.009. Epub 2018 May 24.

PMID:
29804928
30.

Estimating the contribution of studies in network meta-analysis: paths, flows and streams.

Papakonstantinou T, Nikolakopoulou A, Rücker G, Chaimani A, Schwarzer G, Egger M, Salanti G.

Version 3. F1000Res. 2018 May 18 [revised 2018 Jan 1];7:610. doi: 10.12688/f1000research.14770.3. eCollection 2018.

31.

Comparing interventions with network meta-analysis.

Bagg MK, Salanti G, McAuley JH.

J Physiother. 2018 Apr;64(2):128-132. doi: 10.1016/j.jphys.2018.02.014. No abstract available.

32.

Antidepressants might work for people with major depression: where do we go from here?

Cipriani A, Salanti G, Furukawa TA, Egger M, Leucht S, Ruhe HG, Turner EH, Atkinson LZ, Chaimani A, Higgins JPT, Ogawa Y, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JPA, Geddes JR.

Lancet Psychiatry. 2018 Jun;5(6):461-463. doi: 10.1016/S2215-0366(18)30133-0. Epub 2018 Apr 5. No abstract available.

PMID:
29628364
33.

Developing WHO guidelines: Time to formally include evidence from mathematical modelling studies.

Egger M, Johnson L, Althaus C, Schöni A, Salanti G, Low N, Norris SL.

Version 2. F1000Res. 2017 Aug 29 [revised 2018 Jan 1];6:1584. doi: 10.12688/f1000research.12367.2. eCollection 2017.

34.

Psychological interventions for positive symptoms in schizophrenia: protocol for a network meta-analysis of randomised controlled trials.

Bighelli I, Salanti G, Reitmeir C, Wallis S, Barbui C, Furukawa TA, Leucht S.

BMJ Open. 2018 Mar 14;8(3):e019280. doi: 10.1136/bmjopen-2017-019280.

35.

Living network meta-analysis compared with pairwise meta-analysis in comparative effectiveness research: empirical study.

Nikolakopoulou A, Mavridis D, Furukawa TA, Cipriani A, Tricco AC, Straus SE, Siontis GCM, Egger M, Salanti G.

BMJ. 2018 Feb 28;360:k585. doi: 10.1136/bmj.k585. Review.

36.

Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.

Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JPA, Geddes JR.

Lancet. 2018 Apr 7;391(10128):1357-1366. doi: 10.1016/S0140-6736(17)32802-7. Epub 2018 Feb 21. Review.

37.

Outcomes of non-invasive diagnostic modalities for the detection of coronary artery disease: network meta-analysis of diagnostic randomised controlled trials.

Siontis GC, Mavridis D, Greenwood JP, Coles B, Nikolakopoulou A, Jüni P, Salanti G, Windecker S.

BMJ. 2018 Feb 21;360:k504. doi: 10.1136/bmj.k504. Review.

38.

Dismantling cognitive-behaviour therapy for panic disorder: a systematic review and component network meta-analysis.

Pompoli A, Furukawa TA, Efthimiou O, Imai H, Tajika A, Salanti G.

Psychol Med. 2018 Sep;48(12):1945-1953. doi: 10.1017/S0033291717003919. Epub 2018 Jan 25.

39.

Is placebo response in antidepressant trials rising or not? A reanalysis of datasets to conclude this long-lasting controversy.

Furukawa TA, Cipriani A, Leucht S, Atkinson LZ, Ogawa Y, Takeshima N, Hayasaka Y, Chaimani A, Salanti G.

Evid Based Ment Health. 2018 Feb;21(1):1-3. doi: 10.1136/eb-2017-102827. Epub 2018 Jan 12. Review.

PMID:
29330216
40.

Causal inference from experiment and observation.

Zwahlen M, Salanti G.

Evid Based Ment Health. 2018 Feb;21(1):34-38. doi: 10.1136/eb-2017-102859. Epub 2017 Dec 29.

PMID:
29289944
41.

Comparative efficacy and acceptability of pharmacological treatments for post-traumatic stress disorder in adults: a network meta-analysis.

Cipriani A, Williams T, Nikolakopoulou A, Salanti G, Chaimani A, Ipser J, Cowen PJ, Geddes JR, Stein DJ.

Psychol Med. 2018 Sep;48(12):1975-1984. doi: 10.1017/S003329171700349X. Epub 2017 Dec 19.

PMID:
29254516
42.

A model for meta-analysis of correlated binary outcomes: The case of split-body interventions.

Efthimiou O, Mavridis D, Nikolakopoulou A, Rücker G, Trelle S, Egger M, Salanti G.

Stat Methods Med Res. 2019 Jul;28(7):1998-2014. doi: 10.1177/0962280217746436. Epub 2017 Dec 12.

43.

Efficacy of antidepressants over placebo is similar in two-armed versus three-armed or more-armed randomized placebo-controlled trials.

Ogawa Y, Furukawa TA, Takeshima N, Hayasaka Y, Atkinson LZ, Tanaka S, Cipriani A, Salanti G.

Int Clin Psychopharmacol. 2018 Mar;33(2):66-72. doi: 10.1097/YIC.0000000000000201. Review.

44.

Living systematic reviews: 3. Statistical methods for updating meta-analyses.

Simmonds M, Salanti G, McKenzie J, Elliott J; Living Systematic Review Network.

J Clin Epidemiol. 2017 Nov;91:38-46. doi: 10.1016/j.jclinepi.2017.08.008. Epub 2017 Sep 11.

PMID:
28912004
45.

Living systematic review: 1. Introduction-the why, what, when, and how.

Elliott JH, Synnot A, Turner T, Simmonds M, Akl EA, McDonald S, Salanti G, Meerpohl J, MacLehose H, Hilton J, Tovey D, Shemilt I, Thomas J; Living Systematic Review Network.

J Clin Epidemiol. 2017 Nov;91:23-30. doi: 10.1016/j.jclinepi.2017.08.010. Epub 2017 Sep 11.

PMID:
28912002
46.

Multivariate and network meta-analysis of multiple outcomes and multiple treatments: rationale, concepts, and examples.

Riley RD, Jackson D, Salanti G, Burke DL, Price M, Kirkham J, White IR.

BMJ. 2017 Sep 13;358:j3932. doi: 10.1136/bmj.j3932. No abstract available.

47.

Common pitfalls and mistakes in the set-up, analysis and interpretation of results in network meta-analysis: what clinicians should look for in a published article.

Chaimani A, Salanti G, Leucht S, Geddes JR, Cipriani A.

Evid Based Ment Health. 2017 Aug;20(3):88-94. doi: 10.1136/eb-2017-102753. Epub 2017 Jul 24.

PMID:
28739577
48.

An investigation of the impact of using different methods for network meta-analysis: a protocol for an empirical evaluation.

Karahalios AE, Salanti G, Turner SL, Herbison GP, White IR, Veroniki AA, Nikolakopoulou A, Mckenzie JE.

Syst Rev. 2017 Jun 24;6(1):119. doi: 10.1186/s13643-017-0511-x.

49.

Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors.

Leucht S, Leucht C, Huhn M, Chaimani A, Mavridis D, Helfer B, Samara M, Rabaioli M, Bächer S, Cipriani A, Geddes JR, Salanti G, Davis JM.

Am J Psychiatry. 2017 Oct 1;174(10):927-942. doi: 10.1176/appi.ajp.2017.16121358. Epub 2017 May 25. Review.

PMID:
28541090
50.

Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis.

Filippini G, Del Giovane C, Clerico M, Beiki O, Mattoscio M, Piazza F, Fredrikson S, Tramacere I, Scalfari A, Salanti G.

Cochrane Database Syst Rev. 2017 Apr 25;4:CD012200. doi: 10.1002/14651858.CD012200.pub2. Review.

Supplemental Content

Loading ...
Support Center